193.10↑0.35 (0.18%)
04:01 PM,5th Dec 2023BSE : 524828
NSE :
Sector : Health care
ISIN Code : INE278D01018
Last Updated: Dec 05 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 28.00 |
All Time High Date | 15 Nov 1995 |
All Time Low | 0.25 |
All Time Low Date | 03 Dec 1999 |
Incorporated in 1990 as a private limited company BDH Industries (BDHIL) was converted into a public limited company in 1994. It was established to take over a going concern Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and since then it has been manufacturing a wide range of drug formulations in the antibiotic anti-inflamatory and anti-microbial segments.The company's clientele worldwide includes ARM & Company Sumitomo NAPP HELM Greenwood etc. International companies like TROGE Megachem and Multichem too have arrangements to source their requirements from the company. It also has a well-established network of stockists and distributors in various states of the country. BDHIL has received several prestigious awards like Top Export Award Trishul Award Commerce Ministry Award etc.It came out with a public issue in Feb.'95 aggregating Rs 6.10 cr to modernise and expand its production facilities and to augment long-term working capital. BDHIL has entered into a MoU with the Nepothene Group Pvt Ltd Nepal to provide assistance in setting up a pharmaceutical company there. The expansion-cum-modernisation project commenced commercial production from May 1999.During the year 2000-2001 the company has taken up expansion and modernisation project and the project has been financed by Term Loan from Banks. The company has repaid Rs.152.21 lacs of Term Loan.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 111 |
EPS - TTM (₹) [S] | 13.68 |
P/E Ratio (X) [S] | 2.01 |
Face Value (₹) | 10 |
Latest Dividend (%) | 40.00 |
Latest Dividend Date | 02 Aug 2023 |
Dividend Yield (%) | 2.07 |
Book Value Share (₹) [S] | 95.84 |
P/B Ratio (₹) [S] | 2.01 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 187.00 195.90 |
Week Low/High | 180.00 211.00 |
Month Low/High | 180.00 211.00 |
Year Low/High | 108.10 227.00 |
All time Low/High | 2.45 227.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 4.32% | % | 4.72 | 4.85% |
1 Month | -6.51% | % | 7.66 | 8.45% |
3 Month | -1.00% | % | 5.34 | 6.54% |
6 Month | 31.27% | % | 10.37 | 12.16% |
1 Year | 26.87% | % | 10.28 | 11.52% |
3 Year | 134.63% | % | 53.72 | 57.30% |
Chairperson & Managing Direct : Jayashree Nair
Joint Managing Director & CFO : S C Kachhara
Director : Karthika Nair
Independent Director : Dinesh Variar
Independent Director : Bhagirath Singh Sihag
Company Sec. & Compli. Officer : Nikita Phatak
Independent Director : Kairav Trivdi
Registered Office: Nair Baug, Akurli Road Kandivli (E),Mumbai,Maharashtra-400101 Ph: 91-22-28871370/28870834
Email:comp.sec@bdhind.com